护肝片防治抗结核药物肝损害的临床观察
结核;,肺;,护肝片;,药物毒性,,结核;,肺;,护肝片;,药物毒性,1材料与方法,2结果,3讨论,参考文献:
摘要:目的观察护肝片对抗结核药物所致肝损害的防治效果。方法初治肺结核168例,应用“2HRZE(S)/4HR”方案抗结核治疗,治疗组88例,全程加服护肝片;对照组80例,全程加服葡醛内脂片。结果治疗组出现肝损害6例(6.82%),其中 HBsAg阳性患者出现5例(5.68%);对照组出现肝损害26例(32.50%),其中 HBsAg阳性患者出现20例(25.00%)。两组比较有显著性差异(P<0.01)。HBsAg阳性患者在抗结核治疗中肝功能更容易受损害。结论护肝片在防治抗结核药物所致肝损害的发生是有效的,特别是对 HBsAg阳性的结核病患者。关键词:结核; 肺; 护肝片; 药物毒性
The Clinical Observation on the Preventive Effects of HuGan Tablets on Liver Damage Caused by Antituberculosis Drugs
DING Weimin,ZHANG Lijuan,YANG Xiuyun
(The First Affiliated Hospital of Xinxiang Medical College,Weihui 453100,China)
Abstract:ObjectiveTo determine the preventive effect of HuGan Tablets on liver damage caused by anti-tuberculosis drugs.Methods168 initially-treated pulmonary tuberculoses patients who received the regimen of 2HRZE (S) /4HR were randomly separated into 2 groups:study group ,88 cases ,supplemented with Hu-Gan Tablets for 6 months and control group,80 cases,received glucurolactone.ResultsThere were 6 cases who had liver damage in observe group(6.82%) ,5 cases with HBsAg positive (5.68%) . There were 26 cases who had liver damage in control guoup (32.50%) ,20 cases with HBsAg positive (25.00%) .There were significant difference between the 2 groups (P<0.01) .HBsAg positive patients were more likely to have liver damage in antituberculosis treatment.ConclusionHuGan Tablets is effective in preventing and treating liver damage caused by anti-tuberculosis drugs,HBsAg positive patients' liver function should be monitored in the early period of anti-tuberculosis treatment. ......
您现在查看是摘要页,全文长 8798 字符。